Stevens Capital Management LP lowered its position in shares of Clorox Co (NYSE:CLX) by 65.2% in the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 27,605 shares of the company’s stock after selling 51,627 shares during the quarter. Stevens Capital Management LP’s holdings in Clorox were worth $4,227,000 at the end of the most recent reporting period.

Several other hedge funds have also recently added to or reduced their stakes in CLX. Dimensional Fund Advisors LP increased its holdings in shares of Clorox by 8.5% in the fourth quarter. Dimensional Fund Advisors LP now owns 582,745 shares of the company’s stock valued at $89,822,000 after purchasing an additional 45,408 shares during the period. Geode Capital Management LLC increased its holdings in shares of Clorox by 21.5% in the fourth quarter. Geode Capital Management LLC now owns 1,899,544 shares of the company’s stock valued at $292,347,000 after purchasing an additional 335,835 shares during the period. Two Sigma Advisers LP acquired a new position in shares of Clorox in the fourth quarter valued at approximately $355,000. Millennium Management LLC increased its holdings in shares of Clorox by 323.7% in the fourth quarter. Millennium Management LLC now owns 6,643 shares of the company’s stock valued at $1,024,000 after purchasing an additional 9,613 shares during the period. Finally, Truvestments Capital LLC acquired a new position in shares of Clorox in the first quarter valued at approximately $41,000. Institutional investors own 77.01% of the company’s stock.

Shares of Clorox stock traded up $0.32 during trading on Wednesday, reaching $159.28. The company’s stock had a trading volume of 21,783 shares, compared to its average volume of 1,013,049. The company has a quick ratio of 0.55, a current ratio of 0.91 and a debt-to-equity ratio of 4.09. Clorox Co has a 12-month low of $140.82 and a 12-month high of $167.70. The firm has a market capitalization of $20.20 billion, a P/E ratio of 25.30, a P/E/G ratio of 4.98 and a beta of 0.37. The business’s 50 day simple moving average is $158.36.

Clorox (NYSE:CLX) last posted its quarterly earnings results on Thursday, August 1st. The company reported $1.88 earnings per share for the quarter, beating the Zacks’ consensus estimate of $1.84 by $0.04. Clorox had a return on equity of 118.88% and a net margin of 13.20%. The firm had revenue of $1.63 billion for the quarter, compared to the consensus estimate of $1.69 billion. During the same period in the previous year, the business earned $1.66 earnings per share. The company’s revenue for the quarter was down 3.8% compared to the same quarter last year. Analysts predict that Clorox Co will post 6.4 EPS for the current fiscal year.

The firm also recently declared a quarterly dividend, which will be paid on Friday, August 16th. Investors of record on Wednesday, July 31st will be paid a $1.06 dividend. The ex-dividend date of this dividend is Tuesday, July 30th. This is an increase from Clorox’s previous quarterly dividend of $0.96. This represents a $4.24 dividend on an annualized basis and a dividend yield of 2.66%. Clorox’s payout ratio is 67.09%.

A number of research firms have recently issued reports on CLX. Bank of America reissued a “neutral” rating and issued a $154.00 target price (down previously from $165.00) on shares of Clorox in a report on Thursday, May 2nd. Wells Fargo & Co reissued a “hold” rating and issued a $153.00 target price on shares of Clorox in a report on Thursday, August 1st. Deutsche Bank raised Clorox from a “sell” rating to a “hold” rating and set a $139.00 target price on the stock in a report on Thursday, May 2nd. Citigroup set a $156.00 target price on Clorox and gave the company a “hold” rating in a report on Thursday, May 23rd. Finally, ValuEngine lowered Clorox from a “buy” rating to a “hold” rating in a report on Thursday, August 1st. Three research analysts have rated the stock with a sell rating, ten have given a hold rating and two have given a buy rating to the company. Clorox presently has a consensus rating of “Hold” and an average target price of $154.07.

In other Clorox news, SVP Diego J. Barral sold 1,987 shares of the business’s stock in a transaction on Friday, August 2nd. The stock was sold at an average price of $157.59, for a total transaction of $313,131.33. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Also, SVP Denise Garner sold 20,399 shares of the business’s stock in a transaction on Friday, June 7th. The stock was sold at an average price of $157.61, for a total value of $3,215,086.39. Following the sale, the senior vice president now owns 4,896 shares in the company, valued at $771,658.56. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 25,786 shares of company stock worth $4,054,776. Company insiders own 1.40% of the company’s stock.

About Clorox

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Cleaning, Household, Lifestyle, and International. The company offers laundry additives, including bleach products under the Clorox brand, as well as Clorox 2 stain fighter and color booster; home care products primarily under the Clorox, Formula 409, Liquid-Plumr, Pine-Sol, S.O.S, and Tilex brands; naturally derived products under the Green Works brand; and professional cleaning, disinfecting, and food service products under the Clorox, Dispatch, HealthLink, Clorox Healthcare, Hidden Valley, KC Masterpiece, and Soy Vay brands.

See Also: P/E Growth (PEG)

Institutional Ownership by Quarter for Clorox (NYSE:CLX)

Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.